A higher proportion of veterans who use VA pharmacy services are black, have no alternative insurance, have lower incomes, are disabled, and report poorer health.
To compare users and nonusers of Veterans Affairs (VA) pharmacy services by age group.
We used data on sociodemographics, health status, and medical conditions from the Medical Expenditure Panel Survey (MEPS) to compare users and nonusers of VA pharmacies for medications. Data were pooled for 2003-2005 to ensure adequate sample sizes. Student t tests were used to compare the means for each variable, and all analyses were adjusted for the complex sample design of the MEPS.
Among both nonelderly (18-64 years) and elderly (≥65 years) veterans, a higher proportion who used VA pharmacy services versus those who did not use VA pharmacy services (1) were black (nonelderly: 17.7 % vs 7.4%, P <.001; elderly: 9.4% vs 4.7%, P <.001); (2) had no alternative insurance (nonelderly: 27.2% vs 4.8%, P <.001; elderly: 36.3% vs 19.9%, P <.001); (3) had lower incomes (nonelderly: 32.4% vs 11.5%, P <.001; elderly: 32.4% vs 25.4%, P = .01); (4) had less than a high school education (nonelderly: 13.0% vs 6.5%, P <.001; elderly: 27.5% vs 17.6%, P <.001); (5) were disabled; and (6) reported poorer health. A higher percentage of nonelderly users reported a mental health condition (31.6% vs 19.4%, P <.001).
Veterans who use VA pharmacy services appear to be more ill than those who do not use VA pharmacy services. In addition, the VA appears to be a safety net for uninsured veterans who have mental health problems.
(Am J Manag Care. 2009;15(10):701-708)
Knowledge about the users of Veterans Affairs (VA) pharmacy services is valuable when comparing the VA national drug plan with other models of prescription drug coverage because patient characteristics influence the types of medications included in the plans, as well as their level of use.
The Department of Veterans Affairs (VA) provides a comprehensive prescription drug program designed to address the medication needs of veterans, while maintaining low costs.1,2 Most veterans pay $8 for a 30-day supply of each medication they receive, with an annual maximum out-of-pocket expense of $960. However, veterans do not pay for medications associated with a condition that is connected to their military service, and veterans whose incomes are below a certain threshold pay nothing at all. An ongoing challenge for the VA is to provide high levels of service within a fixed budget, rising drug costs, and increasing use of prescription medications. The VA established a pharmacy benefits management (PBM) group in 1995 to manage the drug formulary for the entire VA system,1 which served over 4.4 million veterans in fiscal year 2007 and provided more than 122 million prescriptions. When updating the formulary, staff from the VA PBM consider the available evidence on the efficacy and safety of the drugs, their relevance to the VA population, and their place in therapy relative to currently available medications, as well as cost.2 Previous studies comparing the characteristics of veterans who use VA medical centers for healthcare services with the characteristics of veterans who obtain their care elsewhere have found that, in general, veterans who use the VA have lower incomes and education levels and report poorer health.3,4 In addition, among veterans younger than age 65 years, those who were uninsured were more likely to use the VA for healthcare.3,5 However, these studies did not specifically address the use of VA pharmacy services, and they did not evaluate differences while controlling for age, aside from insurance status.
As prescription drug use and expenditures have risen dramatically over time,6 it is important to focus on veterans who may come to the VA primarily to take advantage of the pharmacy benefit.5 In addition, knowledge about the users of VA pharmacy services is valuable when comparing the VA national drug plan with other models of prescription drug coverage, such as Medicare Part D, because patient characteristics have an effect on the types of medications included in the plans and the level of use of those medications. The VA serves a disproportionately elderly population who are more likely than younger veterans to be heavy users of prescription medications; therefore, it is necessary to adjust for age when comparing VA users with nonusers. In addition, comparing differences in pharmacy use by age could provide insight into futureutilization when, for example, increasing numbers of younger veterans may turn to the VA for healthcare and pharmacy benefits on their return from the wars in Iraq and Afghanistan.
Source of Data
We used data from the Medical Expenditure Panel Survey (MEPS) to compare veterans who were users of VA pharmacy services with those who were nonusers; comparisons were made separately by age group. MEPS data are especially useful for describing these populations because the survey ascertains veteran status and includes detailed information on sociodemographic variables, health status, and medical conditions. The MEPS also measures all healthcare service utilization inside and outside of the VA.
The MEPS, sponsored by the Agency for Healthcare Research and Quality, is an ongoing survey that collects nationally representative data on healthcare utilization, expenditures, sources of payment, insurance coverage, and health status for the civilian, noninstitutionalized population. Additional demographic and socioeconomic data are collected for all individuals in sampled households through computer-assisted personal interviews. Each year approximately 13,000 households and 35,000 individuals are surveyed. The MEPS verifies household reports of payments for medical care services through provider follow-back surveys. To verify the sources of payment for prescribed medicines, respondents are asked for permission to contact their pharmacy, including VA pharmacies. For this analysis, we pooled data from the MEPS for 2003 through 2005 to ensure adequate sample sizes for comparing VA pharmacy users with nonusers by age group. The larger samples reduced the standard errors surrounding the estimates, and smaller standard errors thus allowed us to discuss more statistically significant differences between the groups. At the time, 2005 was the most recent year with complete data.
We defined a treatment group consisting of users of VA pharmacy services. “Users” included veterans who had at least 1 VA pharmacy claim and used the VA for at least 1 inpatient, outpatient, office-based, home health, or dental service. Similarly, we defined a control group of veterans who did not use the VA pharmacy. These “nonusers” consisted of veterans who had at least 1 non-VA pharmacy claim and used at least 1 healthcare service from the list above from a non-VA provider. The treatment and control groups were defined in this manner because it increased the accuracy of the sources of payment for the claims. The MEPS data showed that about 3.3% of veterans had a pharmacy claim, but no other reported use of health services. This may have occurred, in some cases, because an office visit or other physician contact took place prior to data collection. By definition, these individuals were excluded from our analysis.
We defined veterans between the ages of 18 and 64 years as nonelderly and those over the age of 65 years as elderly. For veterans who used VA pharmacy services, the sample sizes were 533 and 638 for the nonelderly and elderly groups, respectively. The sample sizes for veterans who did not use VA pharmacy services were 1555 and 1428 for the nonelderly and elderly groups, respectively. Our results were weighted to be nationally representative of the US civilian, noninstitutionalized population of these age groups.7
Student t tests were used to compare the means for each variable in the 2 groups of veterans. All analyses were adjusted for the complex sample design of the MEPS using SUDAAN version 9.0.1 (Research Triangle Institute, Research Triangle Park, NC).
Using our definition of the treatment group, we found that about 4.2 million veterans used the VA pharmacy on average each year in 2003 through 2005. This estimate matched closely the VA administrative data. This treatment group included 1.8 million veterans younger than age 65 years and 2.4 million veterans age ≥65 years. Our control group of veterans who did not use the VA pharmacy included an average annual total of 11.6 million veterans, of whom 6.1 million were under age 65 years and 5.5 million were age >65 years. displays the sociodemographic characteristics of nonelderly users versus nonusers of VA pharmacy services. presents the same data for elderly veterans.
There were many differences between users and nonusers of VA pharmacy services in the nonelderly veteran population. Users of VA pharmacy services were more likely than nonusers to be black (17.7% vs 7.4%, P <.001), less likely to be married (53.6% vs 76.0%, P <.001), and twice as likely to have less than a high school education (13.0% vs 6.5%, P <.001). In addition, users were much more likely than nonusers to be unemployed or out of the labor force (47.7% vs 19.8%, P <.001) and living in a poor or low-income family (32.4% vs 11.5%, P <.001). Fewer users than nonusers lived in high-income families (40.6% vs 60.0%, P <.001).
Nonelderly users also differed significantly from nonusers in terms of insurance status. More than one-quarter of nonelderly VA pharmacy users were uninsured compared with less than 5% of nonusers (27.2% vs 4.8%, P <.001). In addition, a much larger proportion of users had public coverage compared with nonusers (16.9% vs 3.8%, P <.001). As a result, while 91.4% of nonusers were covered by private insurance, the same was true for only 55.8% of users.
There were fewer differences between elderly users and nonusers of VA pharmacy services. As with the younger age group, elderly users were more likely to be black (9.4% vs 4.7%, P <.001) and have less than a high school education (27.5% vs 17.6%, P <.001) compared with elderly nonusers. But there were no differences in marital or employment status. Income differences were similar but less pronounced, with more users living in poor or low-income families (32.4% vs 25.4%, P = .01) and fewer users living in high-income families (33.3% vs 43.9%, P <.001). In the elderly age group, 57.5% ofveterans who used VA pharmacy services had private insurance (in addition to Medicare) versus 76.0% of nonusers (P <.001), and 36.3% of users had Medicare only versus 19.9% of nonusers (P <.001).
Health Status and Medical Conditions
and present the health status and medical conditions of users versus nonusers of VA pharmacy services in nonelderly and elderly veterans, respectively. Regardless of the age category, veterans who used VA pharmacy services reported poorer health status along many dimensions compared with veterans who did not use the VA pharmacy.
Among nonelderly veterans, users of the VA pharmacy were more than twice as likely to report fair or poor general health status (53.5% vs 21.4%, P <.001) and more than 3 times as likely to report fair or poor mental health status (32.1% vs 10.2%, P <.001) as nonusers. Users also were more likely to report being disabled than nonusers. Specifically, 42.6% of users compared with 18.4% of nonusers reported physical limitations (P <.001). Even larger differences between VA pharmacy users and nonusers were found for activity limitations such as work, school, and housework (40.0% vs 12.3%, P <.001) and cognitive limitations (19.1% vs 4.8%, P <.001). Users were also more likely to report difficulties with activities of daily living (ADLs) and instrumental ADLs (IADLs).
Nonelderly VA pharmacy users were more likely than nonusers to report hypertension (46.3% vs 33.0%, P <.001) and diabetes (24.0% vs 11.6%, P <.001). Mental conditions also were much more common among VA pharmacy users. About 31.6% of users reported having any mental disorder compared with 19.4% of nonusers (P <.001). Focusing solely on depression, 15.9% of users versus 9.2% of nonusers reported this condition (P <.001). Overall, nonelderly VA pharmacy users reported having more conditions as measured by International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes than nonusers (5.8 vs 4.2 conditions, P <.001).
There also were many differences between elderly users and nonusers of VA pharmacies in terms of health status and medical conditions, but these differences were less dramatic. Nearly half of users reported fair or poor health status compared with one-third of nonusers (48.9% vs 33.0%, P <.001). A greater proportion of VA pharmacy users also reported fair or poor mental health versus nonusers (22.0% vs 16.2%, P = .01), but the discrepancy was not as large as that reported for general health status. The difference between the 2 groups was more significant for limitations in physical functioning, with 50.0% of elderly users reporting that they were disabled versus 37.6% of nonusers (P <.001). Similar differences between users and nonusers were seen in activity limitations (36.6% vs 24.6%, P <.001) and cognitive limitations (20.8% vs 12.5%, P <.001). Similarly, elderly users of VA pharmacy services were more likely to report difficulties with ADLs and IADLs than nonusers.
With regard to medical conditions, elderly users of VA pharmacy services were more likely to report having diabetes (28.8% vs 19.1%, P <.001) and gastroesophageal reflux disease/peptic ulcer disease (26.7% vs 16.2%, P <.001) than nonusers. In addition, users reported more medical conditions (mean of 7.7 vs 6.0 conditions, P <.001).
To our knowledge, this is the first national description of the characteristics of veterans who used VA pharmacy services versus those who obtained their medications outside of the VA. Similar to previous studies of veteran users and nonusers of VA healthcare, we found that a higher proportion of veterans who used VA pharmacy services were black, had no alternative insurance, had lower incomes and education levels, and reported poorer physical and mental health.3,4,8 Our study also found that these differences between users and nonusers held true for both nonelderly and elderly veterans, but they were much more pronounced among the nonelderly.
In addition, we found that both nonelderly and elderly users of VA pharmacy services reported more medical conditions and were more disabled, as indicated by a higher percentage identifying physical, activity, and cognitive limitations and difficulties with ADLs and IADLs. Nonelderly users of VA pharmacy services reported the presence of mental health problems, hypertension, and diabetes more frequently. In contrast, only diabetes and gastroesophageal reflux disease/peptic ulcer disease were reported more frequently in elderly users versus nonusers of VA pharmacy services.
These differences in health problems have implications for the resources that are necessary within the VA healthcare system. The VA has experience with treating mental health problems, but these services may need to be expanded as younger veterans return from Iraq and Afghanistan.9,10 A large proportion (27.2%) of nonelderly veterans who use the VA have no other insurance, and 31.6% of them report a mental disorder. Taken together, these findings suggest the VA may be a safety net for nonelderly veterans with mental health conditions. Other studies have found that the likelihood of care for mental health problems is lowest among the uninsured.11,12
The VA also may have been a safety net for elderly veterans without private insurance prior to the implementation of the Medicare Prescription Drug Act because of its coverage of prescription medications.5 As stated previously, our data indicate that elderly veterans who use VA pharmacy services report being treated for a greater number of medical conditions. Therefore, they may be taking more medications. Interestingly, a recent study found that Medicare Part D could reduce expenditures for some veterans living near the poverty level who have incomes above the threshold for a copayment waiver through the VA.13 Our study provides important baseline data that are needed to assess the impact of Medicare Part D on the future use of VA pharmacy services. In addition, knowledge about the users of VA pharmacy services is important when comparing the VA national drug plan with other models of prescription drug coverage, such as Medicare Part D, because patient characteristics, including health status, medical conditions, and disability status, influence the types of medications included in the plans and their degree of use.
Our conclusions are strengthened by the nationally representative and comprehensive data used to conduct our analyses. Unlike administrative data sets, the MEPS includes veterans who have never used the VA pharmacy and covers all sources of potential third-party payers. There are nonetheless some limitations to the MEPS data. First, medical conditions are reported by household respondents and are mainly collected in connection with healthcare use (eg, respondents are asked about the reason for an office visit or purchase of a medication). This situation could lead to underreporting, especially with regard to mental health conditions, although there is no apparent reason why any systematic bias should result with respect to veterans who use and do not use VA pharmacy services. Second, although we combined data from 2003 through 2005, the unweighted number of veterans in the MEPS was small and limited the statistical power for some other comparisons (eg, we could not examine the prevalence of less common medical conditions).
In conclusion, our results indicate that veterans who use VA pharmacy services appear to be more ill than their counterparts who do not use the VA pharmacy benefit. Mental health problems are especially prevalent among nonelderly users, and services for these illnesses may need to be expanded in the future. Our description of the characteristics of veterans who use VA pharmacy services facilitates understanding of their future needs and makes possible more accurate comparisons of the VA model with other models of healthcare, including Medicare, in terms of attributes such as cost and formulary structure.
Author Affiliations: From the VA Center for Medication Safety (SLA, CBG, FEC), Hines, IL; the Center for Health Equity Research and Promotion (SLA, CBG), VA Pittsburgh Healthcare System, Pittsburgh, PA; the School of Pharmacy (SLA, CBG) and the School of Medicine (CBG), University of Pittsburgh, PA; the Center for Financing, Access and Cost Trends (JSB, GEM), Agency for Healthcare Research and Quality, Washington, DC.
Funding Source: There was no funding for this study.
Author Disclosures: The authors (SLA, JSB, CBG, GEM, FEC) report no relationship or financial interest with any entity that would pose a conflict of interest with the subject matter of this article.
The views expressed in this paper are those of the authors, and no official endorsement by the Department of Veteran Affairs, the Department of Health and Human Services, or the Agency for Healthcare Research and Quality is intended or should be inferred.
Authorship Information: Concept and design (SLA, JSB, CBG, GEM, FEC); acquisition of data (JSB, FEC); analysis and interpretation of data (SLA, JSB, CBG, GEM); drafting of the manuscript (SLA, JSB, CBG); critical revision of the manuscript for important intellectual content (JSB, CBG, GEM, FEC); statistical analysis (JSB, GEM); and administrative, technical, or logistic support (FEC).
Address correspondence to: Sherrie L. Aspinall, PharmD, MSc, VA Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, 7180 Highland Dr, Pittsburgh, PA 15206. E-mail: email@example.com.
1. Sales MM, Cunningham FE, Glassman PA, Valentino MA, Good CB. Pharmacy benefits management in the Veterans Health Administration: 1995 to 2003. Am J Manag Care. 2005;11(2):104-112.
2. Good CB, Valentino M. Access to affordable medications: the Department of Veterans Affairs Pharmacy Plan as a national model. Am J Public Health. 2007;97(12):2129-2131.
3. Liu CF, Maciejewski ML, Sales AEB. Changes in characteristics of veterans using the VHA health care system between 1996 and 1999. Health Res Policy Syst. 2005;3(1):5.
4. Nelson KM, Starkebaum GA, Reiber GE. Veterans using and uninsured veterans not using Veterans Affairs (VA) health care. Public Health Rep. 2007;122(1):93-100.
5. Shen Y, Hendricks A, Zhang S, Kazis LE. VHA enrollees’ health care coverage and use of care. Med Care Res Rev. 2003;60(2):253-267.
6. Zuvekas SH, Cohen JW. Prescription drugs and the changing concentration of health care expenditures. Health Aff (Millwood). 2007;26(1):249-257.
7. Ezzati-Rice TM, Rohde F, Greenblatt J. Sample Design of the Medical Expenditure Panel Survey Household Component, 1998-2007. Methodology Report No. 22. March 2008. Agency for Healthcare Research and
Quality, Rockville, MD. http://www.meps.ahrq.gov/mepsweb/data_files/publications/mr22/mr22.pdf. Accessed September 9, 2008.
8. Hynes DM, Koelling K, Stroupe K, et al. Veterans’ access to and use of Medicare and Veterans Affairs health care. Med Care. 2007;45(3):214-223.
9. Hoge CW, Auchterlonie JL, Milliken CS. Mental health problems, use of mental health services, and attrition from military service after returning from deployment to Iraq or Afghanistan. JAMA. 2006;295(9):1023-1032.
10. Milliken CS, Auchterlonie JL, Hoge CW. Longitudinal assessment of mental health problems among active and reserve component soldiers returning from the Iraq war. JAMA. 2007;298(18):2141-2148.
11. Wells KB, Sherbourne CD, Sturm R, Young AS, Burnam MA. Alcohol, drug abuse, and mental health care for uninsured and insured adults. Health Serv Res. 2002;37(4):1055-1065.
12. McAlpine DD, Mechanic D. Utilization of specialty mental health care among persons with severe mental illness: the roles of demographics, need, insurance, and risk. Health Serv Res. 2000;35(1 pt 2):
13. Rupper RW, Bair BD, Sauer BC, Nebeker JR, Shinogle J, Samore M. Out-of-pocket pharmacy expenditures for veterans under Medicare Part D. Med Care. 2007;45(10 suppl 2):S77-S80.